Haleon
↗Weybridge, United Kingdom
Haleon is a global leader in consumer healthcare, established in July 2022 through the demerger of GSK's consumer healthcare business and a joint venture with Pfizer. The company owns a portfolio of world-class brands including Sensodyne, Panadol, Advil, Voltaren, Theraflu, Otrivin, Centrum, and Emergen-C.
Headquartered in the UK, Haleon operates in over 170 markets and focuses on five primary categories: Oral Health, Pain Relief, Vitamins, Minerals and Supplements (VMS), Respiratory Health, and Digestive Health. The company emphasizes science-backed innovation and digital transformation to drive household penetration and health inclusivity.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$14B-$15B
Founded:2022
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:GSK (Former Parent), Pfizer (Former Partner/Shareholder)
STOCK
Exchange:LSE, NYSE
Ticker:HLN
Market Cap:$44B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Topical formulations, Oral solids, Digital health tools
Active Trials:15
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 10
FDA Approvals:12
EMA Approvals:8
CORPORATE STRUCTURE
Subsidiaries:Tianjin TSKF Pharmaceutical Co. Ltd, Haleon US Holdings LLC
Key Partnerships:Salesforce (Agentforce Life Sciences Cloud for AI engagement), Microsoft (Digital transformation partnership)
COMPETITION
Position:Leader
Competitors:Kenvue, Procter & Gamble, Bayer, Reckitt, Sanofi Consumer Healthcare
LEADERSHIP
Key Executives:
Brian McNamara - CEO
Dawn Allen - CFO
Carl Haney - Chief R&D Officer
Board Members:Manvinder Singh (Vindi) Banga (Chair), Nancy Avila, Alan Stewart
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Haleon. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.